Safety of COVID-19 vaccines in patients with immunoinflammatory rheumatic diseases (preliminary data)

Objective: to assess the safety of COVID-19 vaccines in patients with immunoinflammatory rheumatic diseases (IRD) in real clinical practice.Patients and methods. A cross-sectional study of patients with IRD, who were admitted to V.A. Nasonova Research Institute of Rheumatology for inpatient or outpa...

Full description

Bibliographic Details
Main Authors: A. N. Kulikov, N. V. Muravyeva, B. S. Belov
Format: Article
Language:Russian
Published: IMA-PRESS LLC 2022-02-01
Series:Современная ревматология
Subjects:
Online Access:https://mrj.ima-press.net/mrj/article/view/1248